Although the study was primarily set up to measure effects on in situ aromatase within the breast and not designed to determine quantitative changes in endogenous oestrogens (which would be complicated by the infusion of exogenous oestrogen), it was of interest to note that the median decrease in tumour E2 was 67% and in E1 was 70%. Here, CYP19A1 is linked to neoplasm.